Hereditary Cancer in Clinical Practice Q3
Unclaimed
BioMed Central Ltd
United Kingdom
Hereditary Cancer in Clinical Practice is a journal indexed in SJR in Oncology and Genetics (clinical) with an H index of 34. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2290 €. The scope of the journal is focused on cancer genetics. It has an SJR impact factor of 0,648 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,648.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Categories:
Genetics (clinical) (Q3)
Oncology (Q3)
Price
2290 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,648
SJR Impact factor34
H Index26
Total Docs (Last Year)111
Total Docs (3 years)1018
Total Refs217
Total Cites (3 years)106
Citable Docs (3 years)2.18
Cites/Doc (2 years)39.15
Ref/DocOther journals with similar parameters
American Journal of Clinical Oncology Q3
American Journal of Clinical Oncology: Cancer Clinical Trials Q3
Oncology Letters Q3
World Journal of Oncology Q3
Advances in Cancer Research Q3
Compare this journals
Aims and Scope
Cancer genetics
Comments